Johanna Mercier

JOHANNA MERCIER serves as chief commercial officer at Gilead. She is responsible for the global commercialization of all the company’s medicines throughout the product lifecycle. Under her leadership, Gilead works to ensure that patients around the world have access to the company’s transformational medicines. In 2019, Mercier joined Gilead after twenty five years at Bristol-Myers Squibb, where she served in a number of executive leadership positions, gaining broad experience across geographies and in all aspects of the commercial business. In her time there, she successfully evolved the culture and drove strong commercial execution with double-digit growth and multiple launches that changed the standard of care in melanoma and renal cancers. She is a member of the board of the University of Southern California’s Leonard D. Schaeffer Center for Health Policy and Economics. Mercier holds a BS in biology from the University of Montreal and an MBA from Concordia University. @gileadsciences

Want to hear more from our speakers? Sign up for our monthly newsletter, tune into our podcast, or visit the Conference for Women bookstore.